Terms: = Prostate cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Staging
91 results:
1. Preclinical Evaluation of a Novel High-Affinity Radioligand [
Bezverkhniaia E; Kanellopoulos P; Abouzayed A; Larkina M; Oroujeni M; Vorobyeva A; Rosenström U; Tolmachev V; Orlova A
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139219
[TBL] [Abstract] [Full Text] [Related]
2. Enhancing PSMA PET/CT imaging of prostate cancer: investigating the impact of multiple time point evaluation, diuretic administration, cribriform pattern, and intraductal carcinoma.
Guner LA; Unal K; Beylergil V; Tuna MB; Saglican Y; Vardareli E; Kural AR
Ann Nucl Med; 2023 Nov; 37(11):618-628. PubMed ID: 37783903
[TBL] [Abstract] [Full Text] [Related]
3. Presurgical
Djaïleb L; Armstrong WR; Thompson D; Gafita A; Farolfi A; Rajagopal A; Grogan TR; Nguyen K; Benz MR; Hotta M; Barbato F; Ceci F; Schwarzenböck SM; Unterrainer M; Zacho HD; Juarez R; Cooperberg M; Carroll P; Washington S; Reiter RE; Eiber M; Herrmann K; Fendler WP; Czernin J; Hope TA; Calais J
Eur Urol; 2023 Dec; 84(6):588-596. PubMed ID: 37482512
[TBL] [Abstract] [Full Text] [Related]
4. Mismatch repair gene germline mutations in patients with prostate cancer.
Fang B; Wei Y; Pan J; Zhang T; Ye D; Zhu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 52(2):133-138. PubMed ID: 37283096
[TBL] [Abstract] [Full Text] [Related]
5. Baseline PSMA-PET/CT as a predictor of PSA persistence following radical prostatectomy in high-risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy.
Du X; Dong Y; Liu J; Su Y; Zhu Y; Pan J; Dong B; Chen R; Liu J; Tong Z; Pienta KJ; Rowe SP; Dong L; Xue W
Prostate; 2023 Aug; 83(11):1112-1120. PubMed ID: 37165552
[TBL] [Abstract] [Full Text] [Related]
6. [
Vats K; Chakraborty A; Rakshit S; Damle A; Sarma HD; Satpati D
Nucl Med Biol; 2023; 118-119():108331. PubMed ID: 36933456
[TBL] [Abstract] [Full Text] [Related]
7. Federated Learning with Research Prototypes: Application to Multi-Center MRI-based Detection of prostate cancer with Diverse Histopathology.
Rajagopal A; Redekop E; Kemisetti A; Kulkarni R; Raman S; Sarma K; Magudia K; Arnold CW; Larson PEZ
Acad Radiol; 2023 Apr; 30(4):644-657. PubMed ID: 36914501
[TBL] [Abstract] [Full Text] [Related]
8.
Sonni I; Dal Pra A; O'Connell DP; Ells Z; Benz M; Nguyen K; Yoon SM; Deng J; Smith C; Grogan T; Nickols NG; Cao M; Kishan AU; Calais J
J Nucl Med; 2023 Jun; 64(6):902-909. PubMed ID: 36759200
[TBL] [Abstract] [Full Text] [Related]
9. Head-to-Head Comparison of 68 Ga-P16-093 and 68 Ga-PSMA-617 PET/CT in Patients With Primary prostate cancer : A Pilot Study.
Wang G; Li L; Zang J; Hong H; Zhu L; Kung HF; Zhu Z
Clin Nucl Med; 2023 Apr; 48(4):289-295. PubMed ID: 36727866
[TBL] [Abstract] [Full Text] [Related]
10. Impact of choosing wisely on imaging in men with newly diagnosed prostate cancer.
Lange SM; Choudry MM; Hunt TC; Ambrose JP; Haaland BA; Lowrance WT; Hanson HA; O'Neil BB
Urol Oncol; 2023 Jan; 41(1):48.e19-48.e26. PubMed ID: 36307366
[TBL] [Abstract] [Full Text] [Related]
11. Impact of
Basso Dias A; Finelli A; Bauman G; Veit-Haibach P; Berlin A; Ortega C; Avery L; Metser U
Radiology; 2022 Sep; 304(3):600-608. PubMed ID: 35608445
[TBL] [Abstract] [Full Text] [Related]
12. Local Extent of prostate cancer at MRI versus prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes.
Wibmer AG; Nikolovski I; Chaim J; Lakhman Y; Lefkowitz RA; Sala E; Carlsson SV; Fine SW; Kattan MW; Hricak H; Vargas HA
Radiology; 2022 Mar; 302(3):595-602. PubMed ID: 34931855
[TBL] [Abstract] [Full Text] [Related]
13. Single-Center Comparison of [
Mirzaei S; Lipp R; Zandieh S; Leisser A
Curr Oncol; 2021 Oct; 28(5):4167-4173. PubMed ID: 34677271
[TBL] [Abstract] [Full Text] [Related]
14. Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized prostate cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial.
Jones CU; Pugh SL; Sandler HM; Chetner MP; Amin MB; Bruner DW; Zietman AL; Den RB; Leibenhaut MH; Longo JM; Bahary JP; Rosenthal SA; Souhami L; Michalski JM; Hartford AC; Amin PP; Roach M; Yee D; Efstathiou JA; Rodgers JP; Feng FY; Shipley WU
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):294-303. PubMed ID: 34481017
[TBL] [Abstract] [Full Text] [Related]
15. Pan-cancer analysis of prognostic metastatic phenotypes.
Zaorsky NG; Wang X; Garrett SM; Lehrer EJ; Lin C; DeGraff DJ; Spratt DE; Trifiletti DM; Kishan AU; Showalter TN; Park HS; Yang JT; Chinchilli VM; Wang M
Int J Cancer; 2022 Jan; 150(1):132-141. PubMed ID: 34287840
[TBL] [Abstract] [Full Text] [Related]
16. Imaging of prostate cancer: optimizing affinity to prostate specific membrane antigen by spacer modifications in a tumor spheroid model.
Krishnan MA; Pandit A; Sharma R; Chelvam V
J Biomol Struct Dyn; 2022; 40(20):9909-9930. PubMed ID: 34180367
[TBL] [Abstract] [Full Text] [Related]
17. Disparities in prostate cancer diagnosis, treatment, and survival among men with disabilities: Retrospective cohort study in South Korea.
Shin DW; Park J; Yeob KE; Yoon SJ; Jang SN; Kim SY; Park JH; Park JH; Kawachi I
Disabil Health J; 2021 Oct; 14(4):101125. PubMed ID: 34148851
[TBL] [Abstract] [Full Text] [Related]
18. Association of prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk prostate cancer With Active Surveillance.
Nelson TJ; Javier-DesLoges J; Deka R; Courtney PT; Nalawade V; Mell L; Murphy J; Parsons JK; Rose BS
JAMA Netw Open; 2021 May; 4(5):e219452. PubMed ID: 33999164
[TBL] [Abstract] [Full Text] [Related]
19. Limited versus Extended Pelvic Lymph Node Dissection for prostate cancer: A Randomized Clinical Trial.
Touijer KA; Sjoberg DD; Benfante N; Laudone VP; Ehdaie B; Eastham JA; Scardino PT; Vickers A
Eur Urol Oncol; 2021 Aug; 4(4):532-539. PubMed ID: 33865797
[TBL] [Abstract] [Full Text] [Related]
20. A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of prostate Specific Membrane Antigen PET/CT with
Pienta KJ; Gorin MA; Rowe SP; Carroll PR; Pouliot F; Probst S; Saperstein L; Preston MA; Alva AS; Patnaik A; Durack JC; Stambler N; Lin T; Jensen J; Wong V; Siegel BA; Morris MJ
J Urol; 2021 Jul; 206(1):52-61. PubMed ID: 33634707
[TBL] [Abstract] [Full Text] [Related]
[Next]
